CAMP4 Therapeutics Corp. (CAMP)
3.17
+0.01
(+0.32%)
USD |
NASDAQ |
Oct 21, 13:07
CAMP4 Therapeutics Gross Profit Margin (Quarterly) : 71.89% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 71.89% |
| March 31, 2026 | 59.81% |
| December 31, 2025 | -6.90% |
| September 30, 2025 | 47.67% |
| June 30, 2025 | 71.28% |
| March 31, 2025 | 50.93% |
| Date | Value |
|---|---|
| December 31, 2024 | 35.89% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -14.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| MannKind Corp. | 69.00% |
| Ocugen, Inc. | 60.62% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -303.7% |
| Return on Assets | -118.0% |
| Return on Invested Capital | -272.7% |
| Profit Margin (Quarterly) | -1.88K% |
| Operating Margin (Quarterly) | -752.1% |
| Return on Net Operating Assets | -1.57K% |